JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
iShares MSCI Australia ETF
EWA
$1.21B
| $3.06M | ﹤0.01% |
137,606
+45,213
| +49% | +$1,000K |
2013 Q2
25 quarters
|
|
|
IVC
2977
DELISTED
Invacare Corporation
IVC
| $3.06M | ﹤0.01% |
407,543
+15,379
| +4% | +$86.3K |
2016 Q1
14 quarters
|
|
|
RLH
2978
DELISTED
Red Lions Hotel Corporation
RLH
| $3.05M | ﹤0.01% |
470,852
+5,594
| +1% | +$34.9K |
2017 Q4
7 quarters
|
|
2979
First Bancorp
FBNC
$2.58B
| $3.05M | ﹤0.01% |
84,858
+2,384
| +3% | +$85.5K |
2013 Q2
25 quarters
|
|
|
CMCT
2980
Creative Media & Community Trust
CMCT
$12.2M
| $3.04M | ﹤0.01% |
+8
| New | +$9.26M |
2017 Q3
8 quarters
|
|
|
FTSV
2981
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $3.04M | ﹤0.01% |
473,867
+94,136
| +25% | +$773K |
2018 Q2
5 quarters
|
|
|
CIVI
2982
DELISTED
Civitas Resources
CIVI
| $3.04M | ﹤0.01% |
135,812
+129,221
| +1,961% | +$2.87M |
2017 Q2
9 quarters
|
|
2983
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.59B
| $3.04M | ﹤0.01% |
112,498
+18,315
| +19% | +$495K |
2013 Q2
25 quarters
|
|
2984
CALL
Nokia
NOK
$59.3B
| $3.04M | ﹤0.01% |
600,000
| – | – |
2017 Q4
7 quarters
|
|
|
TCRR
2985
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $3.04M | ﹤0.01% |
202,016
+9,679
| +5% | +$151K |
2019 Q1
2 quarters
|
|
2986
OneSpan
OSPN
$668M
| $3.03M | ﹤0.01% |
208,992
+40,986
| +24% | +$594K |
2015 Q4
15 quarters
|
|
|
FNHC
2987
DELISTED
FedNat Holding Company Common Stock
FNHC
| $3.03M | ﹤0.01% |
216,385
+17,299
| +9% | +$226K |
2016 Q4
11 quarters
|
|
|
HES
2988
PUT
DELISTED
Hess
HES
| $3.02M | ﹤0.01% |
+50,000
| New | +$3.12M |
2019 Q3
0 quarters
|
|
2989
CALL
Motorola Solutions
MSI
$74B
| $3.02M | ﹤0.01% |
+17,700
| New | +$3.04M |
2019 Q3
0 quarters
|
|
2990
CALL
HCA Healthcare
HCA
$92.4B
| $3.01M | ﹤0.01% |
25,000
-84,000
| -77% | -$10.9M |
2019 Q2
1 quarter
|
|
|
2991
PUT
HCA Healthcare
HCA
$92.4B
| $3.01M | ﹤0.01% |
25,000
-132,400
| -84% | -$17.1M |
2017 Q2
9 quarters
|
|
2992
Avantis US Equity ETF
AVUS
$14.6B
| $3.01M | ﹤0.01% |
+60,000
| New | +$3M |
2019 Q3
0 quarters
|
|
2993
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$570M
| $3M | ﹤0.01% |
97,195
+52,643
| +118% | +$1.58M |
2014 Q4
19 quarters
|
|
2994
First Trust Emerging Markets AlphaDEX Fund
FEM
$813M
| $3M | ﹤0.01% |
126,895
-1,679
| -1% | -$40.5K |
2016 Q3
12 quarters
|
|
|
FLY
2995
DELISTED
Fly Leasing Limited
FLY
| $2.99M | ﹤0.01% |
145,882
+60,989
| +72% | +$1.14M |
2018 Q2
5 quarters
|
|
|
DERM
2996
DELISTED
Dermira, Inc.
DERM
| $2.99M | ﹤0.01% |
468,070
-314,153
| -40% | -$2.62M |
2015 Q4
15 quarters
|
|
2997
CALL
Caesars Entertainment
CZR
$6.04B
| $2.99M | ﹤0.01% |
75,000
| – | – |
2019 Q1
2 quarters
|
|
|
2998
PUT
Caesars Entertainment
CZR
$6.04B
| $2.99M | ﹤0.01% |
75,000
| – | – |
2019 Q1
2 quarters
|
|
2999
Choice Hotels
CHH
$4.61B
| $2.98M | ﹤0.01% |
33,538
+11,580
| +53% | +$1.03M |
2014 Q3
20 quarters
|
|
3000
CALL
Boston Scientific
BSX
$61.7B
| $2.98M | ﹤0.01% |
+73,300
| New | +$3.11M |
2019 Q3
0 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.